nordnet studio
Categories VIDEO Posted on

Nordnet Live – Meet CS Medica

From Thu, Aug 19, 2021

CS MEDICA is a Danish medico company, founded in 2011, specializing in developing, manufacturing and marketing medical equipment and cosmetics containing cannabinoids. The products are bought without a prescription and have a special focus on cannabidiol (CBD) properties for the treatment of psoriasis, arthritis and hair loss – disorders that are a great burden for both patients and society. The company has so far successfully launched 11 products on the European market and will launch a further 9 products by the end of 2022. CS MEDICA is seeking external capital in connection with their upcoming IPO. 

For further information, please contact

Lone Henriksen, CEO
Tel: +45 7070 7337
E-mail: lh@cs-medica.com

About CS MEDICA

CS MEDICA A/S is a Danish medico cannabis company founded in 2011. CS MEDICA is committed to developing, manufacturing, and commercializing over-the-counter (OTC) medical device products containing cannabinoids. The Company runs its business through the two fully-owned subsidiaries, Galaxa Pharma A/S (distributor and representative of foreign manufacturers in the Nordic, registered medical device product distributor) and CanNordic A/S (Medical device developer and seller (BtB), registered medical device product  manufacturer). CS MEDICA distributes products across the European borders and is headquartered in Copenhagen, Denmark.

The company is listed on Spotlight Stockmarked Market in Stockholm (symbol: “CSMED”). For more information about CS MEDICA cs-medica.com.

Advisors, selling agent, and issuing agency
Sedermera Fondkommission is the financial advisor, Phone: +46 (0) 40 615 14 10, info@sedermera.se. Markets & Corporate Law Nordic is the legal advisor to CS MEDICA in connection with the planned capitalization and listing. Nordic Issuing acts as issuing agency and Nordnet Bank AB is the selling agent.

Copyright © 2021 CS MEDICA . All rights reserved.

Our GDPR & Cookie Policy